Atypical femoral fractures in bisphosphonate therapy;Atypische Femurfrakturen unter Bisphosphonat-Therapie

Unfallchirurg

Volumn 118, Issue 1, 2015, Pages 88-91

  Ballaschk, A ^a   Kalaitzis, N ^a   Ropke M ^a   Piatek, S ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Bisphosphonates; Fractures, femoral; Fractures, osteoporotic; Fractures, stress; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; CASE REPORT; CHEMICALLY INDUCED; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMAN; MALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; MALE;

EID: 84891807624     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-013-2526-7     Document Type: Article

References (11)

1. Black DM, Thompson DE, Bauer DC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85(11):4118–4124
2. Dell RM, Adams AL, Greene DF et al (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27(12):2544–2550
3. Donnelly E, Meredith DS, Nguyen JT et al (2012) Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 27(3):672–678
4. Lenart, BA, Neviaser AS, Lyman S et al (2009) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 20(8):1353–1362
5. Nieves, JW, Cosman F (2010) Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep 8(1):34–39
6. Odvina CV, Zerwekh JE, Rao DS et al (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294–1301
7. Park-Wyllie, LY, Mamdani MM, Juurlink DN et al (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305(8):783–789
8. Pfeifer M, Klanke J (2011) Beispiel einer atypischen subtrochantären Femurschaftfraktur nach langjähriger Bisphosphonat-Behandlung. Osteologie 20(1):53
9. Saleh A, Hedge VV, Potty AG, Lane JM (2013) Bisphosphonate therapy and atypical fractures. Orthop Clin North Am 44(2):137–151
10. Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25(11):2267–2294
11. DVO (2009) DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen: Langfassung. DVO, Essen